在杜氏肌营养不良缺失模型中,模板辅助序列敲入可挽救骨骼肌和心肌功能。

IF 12.1 1区 医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Sina Fatehi,Matthew J Rok,Ryan M Marks,Emily Huynh,Natalie Kozman,Hong Anh Truong,Lijun Chi,Bei Yan,Enzhe Khazeeva,Paul Delgado-Olguin,Evgueni A Ivakine,Ronald D Cohn
{"title":"在杜氏肌营养不良缺失模型中,模板辅助序列敲入可挽救骨骼肌和心肌功能。","authors":"Sina Fatehi,Matthew J Rok,Ryan M Marks,Emily Huynh,Natalie Kozman,Hong Anh Truong,Lijun Chi,Bei Yan,Enzhe Khazeeva,Paul Delgado-Olguin,Evgueni A Ivakine,Ronald D Cohn","doi":"10.1016/j.ymthe.2025.05.005","DOIUrl":null,"url":null,"abstract":"Duchenne muscular dystrophy (DMD) poses challenges in therapy design due to dystrophin's complex role in maintaining muscle function since the restoration of truncated protein products has failed to completely address the disease's pathophysiology in clinical trials. As ∼70% of patients harbour deletions, strategies enabling targeted DNA insertion to restore full-length dystrophin protein are essential. Here, we present template-assisted sequence knock-in (TASK), a strategy that we employed to specifically correct the Dmd Δ52-54 mutation in a murine model. By co-delivering a repair template and the Cas9 nuclease using AAV9s, the splice-competent sequence for Dmd exons 52-54 was integrated into the residual intron 54 locus, resulting in the systemic restoration of full-length dystrophin at therapeutically relevant levels in the heart and across all skeletal muscles, leading to significant functional improvements. TASK demonstrates the highest efficiency of exogenous DNA knock-in reported to date, achieving rescue of key dystrophic hallmarks in a deletion model of DMD.","PeriodicalId":19020,"journal":{"name":"Molecular Therapy","volume":"16 1","pages":""},"PeriodicalIF":12.1000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Template-assisted sequence knock-in rescues skeletal and cardiac muscle function in a deletion model of Duchenne muscular dystrophy.\",\"authors\":\"Sina Fatehi,Matthew J Rok,Ryan M Marks,Emily Huynh,Natalie Kozman,Hong Anh Truong,Lijun Chi,Bei Yan,Enzhe Khazeeva,Paul Delgado-Olguin,Evgueni A Ivakine,Ronald D Cohn\",\"doi\":\"10.1016/j.ymthe.2025.05.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Duchenne muscular dystrophy (DMD) poses challenges in therapy design due to dystrophin's complex role in maintaining muscle function since the restoration of truncated protein products has failed to completely address the disease's pathophysiology in clinical trials. As ∼70% of patients harbour deletions, strategies enabling targeted DNA insertion to restore full-length dystrophin protein are essential. Here, we present template-assisted sequence knock-in (TASK), a strategy that we employed to specifically correct the Dmd Δ52-54 mutation in a murine model. By co-delivering a repair template and the Cas9 nuclease using AAV9s, the splice-competent sequence for Dmd exons 52-54 was integrated into the residual intron 54 locus, resulting in the systemic restoration of full-length dystrophin at therapeutically relevant levels in the heart and across all skeletal muscles, leading to significant functional improvements. TASK demonstrates the highest efficiency of exogenous DNA knock-in reported to date, achieving rescue of key dystrophic hallmarks in a deletion model of DMD.\",\"PeriodicalId\":19020,\"journal\":{\"name\":\"Molecular Therapy\",\"volume\":\"16 1\",\"pages\":\"\"},\"PeriodicalIF\":12.1000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ymthe.2025.05.005\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ymthe.2025.05.005","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

由于肌营养不良蛋白在维持肌肉功能方面的复杂作用,杜氏肌营养不良症(DMD)的治疗设计面临挑战,因为在临床试验中,恢复截断的蛋白产物未能完全解决该疾病的病理生理。由于约70%的患者存在缺失,因此能够靶向DNA插入以恢复全长肌营养不良蛋白的策略是必不可少的。在这里,我们提出了模板辅助序列敲入(TASK),这是一种我们用来特异性纠正小鼠模型中Dmd Δ52-54突变的策略。通过使用AAV9s共同递送修复模板和Cas9核酸酶,Dmd外显子52-54的剪接能力序列被整合到剩余的内含子54位点,导致心脏和所有骨骼肌全长肌营养不良蛋白的系统恢复达到治疗相关水平,导致显著的功能改善。TASK展示了迄今为止报道的外源DNA敲入的最高效率,在DMD缺失模型中实现了关键营养不良标志的拯救。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Template-assisted sequence knock-in rescues skeletal and cardiac muscle function in a deletion model of Duchenne muscular dystrophy.
Duchenne muscular dystrophy (DMD) poses challenges in therapy design due to dystrophin's complex role in maintaining muscle function since the restoration of truncated protein products has failed to completely address the disease's pathophysiology in clinical trials. As ∼70% of patients harbour deletions, strategies enabling targeted DNA insertion to restore full-length dystrophin protein are essential. Here, we present template-assisted sequence knock-in (TASK), a strategy that we employed to specifically correct the Dmd Δ52-54 mutation in a murine model. By co-delivering a repair template and the Cas9 nuclease using AAV9s, the splice-competent sequence for Dmd exons 52-54 was integrated into the residual intron 54 locus, resulting in the systemic restoration of full-length dystrophin at therapeutically relevant levels in the heart and across all skeletal muscles, leading to significant functional improvements. TASK demonstrates the highest efficiency of exogenous DNA knock-in reported to date, achieving rescue of key dystrophic hallmarks in a deletion model of DMD.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Therapy
Molecular Therapy 医学-生物工程与应用微生物
CiteScore
19.20
自引率
3.20%
发文量
357
审稿时长
3 months
期刊介绍: Molecular Therapy is the leading journal for research in gene transfer, vector development, stem cell manipulation, and therapeutic interventions. It covers a broad spectrum of topics including genetic and acquired disease correction, vaccine development, pre-clinical validation, safety/efficacy studies, and clinical trials. With a focus on advancing genetics, medicine, and biotechnology, Molecular Therapy publishes peer-reviewed research, reviews, and commentaries to showcase the latest advancements in the field. With an impressive impact factor of 12.4 in 2022, it continues to attract top-tier contributions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信